1-3 of 3
Lei Guo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer

Jeanne M. Quinn, Molly M. Greenwade, Marguerite L. Palisoul, Gregory Opara, Katina Massad, Lei Guo, Peinan Zhao, Hollie Beck-Noia, Ian S. Hagemann, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Katherine C. Fuh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (2): 389–398.
https://doi.org/10.1158/1535-7163.MCT-18-0537
Published: 04 February 2019
View article titled, Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer
Open the PDF for Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer

Marguerite L. Palisoul, Jeanne M. Quinn, Emily Schepers, Ian S. Hagemann, Lei Guo, Kelsey Reger, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Katherine C. Fuh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2881–2891.
https://doi.org/10.1158/1535-7163.MCT-17-0587
Published: 03 December 2017
View article titled, Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer
Open the PDF for Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of topoisomerase IIα and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials

Lei Guo, Xiaojun Liu, Kiyohiro Nishikawa, William Plunkett
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1501–1508.
https://doi.org/10.1158/1535-7163.MCT-06-0780
Published: 18 May 2007
View article titled, Inhibition of topoisomerase IIα and G<sub>2</sub> cell cycle arrest by NK314, a novel benzo[<em>c</em>]phenanthridine currently in clinical trials
Open the PDF for Inhibition of topoisomerase IIα and G<sub>2</sub> cell cycle arrest by NK314, a novel benzo[<em>c</em>]phenanthridine currently in clinical trials in another window